I'll be doing a DCF and risk based valuations and sharing here for feedback. In the meantime, please feel free to attach any broker reports.
Here is the Sep 2024 and March 2025 BP research
EBR Analyst Reports and Valuation Thread Post FDA approval., page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
-0.010(0.71%) |
Mkt cap ! $629.3M | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.42 | $1.37 | $414.4K | 298.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 400 | $1.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 17270 | 1 |
View Market Depth
| Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
| EBR (ASX) Chart |